Changes after publication

Changes after publication

February 2014: implementation section updated to clarify that dabigatran etexilate is recommended as an option for the prevention of venous thromboembolism after hip or knee replacement surgery. Additional minor maintenance update also carried out.

March 2012: minor maintenance

  • National Institute for Health and Care Excellence (NICE)